## CSCO: Cisco Systems, Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_20 0.2% below STRENGTH zone (4.0-10.0%); PEG 1.87 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: declining volume (50% of avg), momentum weakening (-3.5% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($72.58)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 5, Bearish: 0)

**1. UBS Raises Cisco Systems (CSCO) Price Target After Strong Hyperscale Customer Growth**
- Source: Yahoo Finance | 20251129T180900 | Bullish | Relevance: 99%
- UBS increased its price target for Cisco Systems (CSCO) to $90 from $88, maintaining a Buy rating. This adjustment follows Cisco's strong quarterly earnings beat and improved forecast, driven by robust demand from hyperscale customers, service providers, and AI infrastructure investments. The Networking division's 15% year-over-year increase significantly contributed to the earnings exceeding projections.

**2. Shelton Capital Management Has $63.80 Million Stake in Cisco Systems, Inc. $CSCO**
- Source: MarketBeat | 20251201T122925 | Bullish | Relevance: 98%
- Shelton Capital Management significantly increased its stake in Cisco Systems, Inc. by 33.6% during the second quarter, valuing its holdings at $63.80 million and making Cisco its 10th biggest holding. Numerous other institutional investors also adjusted their positions in CSCO. The article also details recent analyst ratings forecasting a "Moderate Buy" consensus, insider trading activity, and Cisco's recent financial performance and dividend declaration.

**3. UBS Raises Cisco Systems (CSCO) Price Target After Strong Hyperscale Customer Growth**
- Source: Insider Monkey | 20251129T130900 | Bullish | Relevance: 98%
- UBS has increased its price target for Cisco Systems Inc. (NASDAQ:CSCO) to $90 from $88, maintaining a Buy rating on the stock. This adjustment follows Cisco's strong quarterly earnings beat and improved forecast, driven by robust demand from hyperscale customers, service providers, and investments in AI infrastructure. The firm anticipates that new product ramps will help Cisco achieve its long-term revenue growth goal of 4%-6% for fiscal years 2026 and 2027.

**4. Mackenzie Financial Corp Buys 1,667,978 Shares of Cisco Systems, Inc. $CSCO**
- Source: MarketBeat | 20251129T123147 | Somewhat-Bullish | Relevance: 98%
- Mackenzie Financial Corp significantly increased its stake in Cisco Systems, Inc. by purchasing an additional 1,667,978 shares, bringing its total ownership to 4,285,084 shares valued at $297.3 million. This comes amidst various analyst ratings, with a consensus of "Moderate Buy" and an average price target of $84.14, along with recent insider selling activity and the announcement of a quarterly dividend. The article details Cisco's financial performance, including beating earnings estimates and revenue growth.

**5. Cisco Systems, Inc. $CSCO Shares Sold by Distillate Capital Partners LLC**
- Source: MarketBeat | 20251201T101449 | Somewhat-Bullish | Relevance: 98%
- Distillate Capital Partners LLC significantly reduced its stake in Cisco Systems, Inc. by 20.4% in Q2, making CSCO its 8th largest position. Other institutional investors like Bare Financial Services Inc. and Financial Connections Group Inc. have increased their holdings. Insider selling by CEO Charles Robbins and Jeetendra I. Patel also occurred, while analysts have largely issued "Buy" or "Outperform" ratings with increased price targets for the company.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 12, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-13 | Barclays | $76 | $71 | +7% |
| 2025-11-13 | Citigroup | $85 | $80 | +6% |
| 2025-11-13 | JP Morgan | $90 | $80 | +12% |
| 2025-11-13 | Wells Fargo | $95 | $83 | +14% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-13 | Barclays | main | Equal-Weight |
| 2025-11-13 | Citigroup | main | Buy |
| 2025-11-13 | JP Morgan | main | Overweight |
| 2025-11-13 | Wells Fargo | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 13 ($0.06M) |
| Sells | 21 ($42.23M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 35.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 10.0% (+0.2%)
- Blackrock Inc.: 9.5% (+1.8%)
- State Street Corpora: 4.9% (-0.1%)
- Geode Capital Manage: 2.6% (+1.8%)
- Charles Schwab Inves: 1.9% (-0.4%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-3.5% 5d) with bearish MACD, trend may be turning.
2. Heavy insider selling: $42M sold (21 transactions in 90 days).
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Analyst target momentum: 12 raises (avg +12%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 1.87 elevated, pricing in significant growth expectations. Forward P/E 17.0x stretched relative to 8% growth. Quality metrics strong (ROE 22%, margin 18%). Balance sheet: $2.9B free cash flow. Analyst sentiment positive (12 raises, avg +12%). Insider selling cluster ($42.2M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $317.1B |
| Beta | 0.86 |
| 52W Range | $52.11 - $80.81 |
| Short Interest | 1.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.87 |
| Forward P/E | 17.0 |
| Current P/E | 18.5 |
| YoY Growth | 8.4% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 3.8% to 0.2% (-3.5% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.8pp (needs >4.0% for momentum thesis). MRS_5 (-0.9%) diverging from MRS_20 - short-term weakness emerging. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 57. Volume at 50% of 20MA suggests lack of conviction.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.22% (CS: 54) | Neutral |
| RSI_14 | 57.2 | Neutral |
| MACD Histogram | -0.14 | Bearish |
| vs SMA20 | 1.013x | Above |
| vs SMA50 | 1.061x | Above |
| vs SMA200 | 1.150x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $76.04
- **Stop Loss:** $72.58 (4.6% risk)
- **Target:** $79.50 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 346
- **Position Value:** $26,309.84
- **Portfolio %:** 26.31%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | IGNITION (Zone D) | 1.20x |

### Earnings

**Next:** 2026-02-11 (Est: $1.02)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $0.98 | $1.00 | +1.8% |
| 2025Q3 | $0.98 | $0.99 | +1.3% |
| 2025Q2 | $0.92 | $0.96 | +4.6% |
| 2025Q1 | $0.91 | $0.94 | +3.4% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*